Innovative Designs and Logistical Considerations for Expedited Clinical Development of Combination Disease-Modifying Treatments for Type 1 Diabetes

What is it about?

Our perspective paper outlines suggestions for accelerating evaluation of candidate disease modifying therapies for type 1 diabetes prevention and treatment by use of innovative trial designs, enhanced logistical coordination of efforts, and regulatory guidances for expedited development, combination therapies, and adaptive designs.

Featured Image